Related Experiment Video
Updated: Jan 29, 2026
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
2.0K
Evidence-based Strategies for Advanced Heart Failure.
1Department of Cardiology, East Jefferson General Hospital, 4224 Houma Boulevard, Suite 530, Metairie, LA 70006, USA.
Critical Care Nursing Clinics of North America
|February 10, 2019
Summary
This article reviews advanced heart failure treatments. It covers guideline-directed medical therapies and advanced options for late-stage heart failure when compensatory mechanisms fail.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Heart failure (HF) is a complex syndrome involving multiple organ systems.
- Disease progression and patient functional class influence treatment strategies.
- Neurohormonal and compensatory mechanisms can become resistant to standard therapies.
Purpose of the Study:
- To outline treatments for advanced heart failure.
- To review guideline-directed medical therapies (GDMT) in the context of late-stage HF.
- To discuss therapeutic options when GDMT becomes insufficient.
Main Methods:
- Literature review of guideline-directed medical therapies for heart failure.
- Analysis of treatment progression into advanced stages of heart failure.
- Synthesis of current therapeutic approaches for end-stage heart failure.
Main Results:
- Standard therapies may become ineffective as heart failure progresses.
- Advanced therapies are necessary when compensatory mechanisms fail.
- A staged approach to treatment is crucial for managing heart failure.
Conclusions:
- Effective management of advanced heart failure requires understanding disease stages.
- Guideline-directed medical therapies form the foundation, but advanced options are critical.
- Treatment must adapt as neurohormonal systems become resistant and fail.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
894
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
894
01:17Pathophysiology of Heart Failure
3.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
01:27Heart Failure I: Introduction
865
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
865
01:22Heart Failure VI: Adjunct Therapies
329
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
329
01:22Heart Failure Drugs: Diuretics
963
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963
01:30Heart Failure V: Medical Management
305
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
305